This activity is supported by educational grants from

Amgen, Inc. Celgene Corporation Cephalon Oncology Eisai Inc. Lilly USA, LLC Genentech BioOncology / Biogen Idec Genzyme Corporation Millennium Pharmaceuticals, Inc. Novartis sanofi-aventis Group
 
  1) Disclosure information available prior to the event
2) Available slides have been authorized for your reference by the presenter.
 

Chair 
Ruemu E. Birhiray, MD
Hematology-Oncology of Indiana
Indianapolis, Indiana


bio | disclosures | slides

Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts

bio | disclosures | slides

James O. Armitage, MD
University of Nebraska Medical Center
Omaha, Nebraska

bio | disclosures | slides

Richard W. Childs, MD, CMDR, USPHS
Bethesda, Maryland

bio | disclosures | slides

Neil E. Kay, MD
Mayo Clinic College of Medicine
Rochester, Minnesota

bio | disclosures | slides

Craig M. Kessler, MD
Georgetown University Medical Center
Washington, District of Columbia

bio | disclosures | slides

Larry W. Kwak, MD, PhD
MD Anderson Cancer Center
Houston, Texas

bio | disclosures | slides

 

Co-Chair
Michael C. Wiemann, MD
Providence Hospital/St. John Health
Warren, Michigan

bio | disclosures

Richard A. Larson, MD
University of Chicago
Chicago, Illinois

bio | disclosures | slides

David G. Maloney, MD, PhD
University of Washington
Seattle, Washington

bio | disclosures | slides

Richard M. Stone, MD
Dana-Farber Cancer Institute
Boston, Massachusetts

bio | disclosures | slides

Martin S. Tallman, MD
Northwestern University Medical Center
Chicago, Illinois

bio | disclosures | slides

Ayalew Tefferi, MD
Mayo Clinic
Rochester, Minnesota

bio | disclosures | slides